Euda Health【EUDA】銘柄情報

Euda Health Holdings Ltd (EUDA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

16.49

( - )

買値

16.30

売値

17.40

出来高

172

16.49 日の範囲 16.49

0.3269 52 週間の範囲 25.70

時価総額

49.376M

前日終値

16.49

始値

16.49

時刻

16.54

最終取引時間

22:49:23

財務取引量

US$ 2,836

VWAP

16.49

平均取引量 (3 か月)

US$ 116,832

発行済株式数

2,994,325

配当利回り

PER

-10.24

1 株当たり利益 (EPS)

-1.48

歳入

6.82M

純利益

-2.77M

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. T... EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

eudahealth.com

本社

Singapore, Singapore

設立

2026

Euda Health Holdings Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker EUDA. The last closing price for Euda Health was US$16.49. Over the last year, Euda Health shares have traded in a share price range of US$ 0.3269 to US$ 25.70.

Euda Health currently has 2,994,325 shares in issue. The market capitalisation of Euda Health is US$49.38 million. Euda Health has a price to earnings ratio (PE ratio) of -10.24.

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the...

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”), a...

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

SINGAPORE, April 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based...

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

Singapore, April 27, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS...

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.99	6.38709677419	15.5	17	15	2895	15.65578653	CS
4	-1.67	-9.19603524229	18.16	18.9	15	5461	17.07533404	CS
12	5.05	44.1433566434	11.44	25.7	5.26	124313	12.19138416	CS
26	13.6	470.588235294	2.89	25.7	0.3269	333791	3.75222637	CS
52	12.84	351.780821918	3.65	25.7	0.3269	213231	3.45218239	CS
156	15.14	1121.48148148	1.35	25.7	0.3269	137831	2.93050553	CS
260	11.59	236.530612245	4.9	25.7	0.3269	235274	2.69599425	CS

EUDA - Frequently Asked Questions (FAQ)

What is the current Euda Health Holdings Ltd share price?

The current share price of Euda Health Holdings Ltd is US$ 16.49

How many Euda Health Holdings Ltd shares are in issue?

Euda Health Holdings Ltd has 2,994,325 shares in issue

What is the market cap of Euda Health Holdings Ltd?

The market capitalisation of Euda Health Holdings Ltd is USD 49.38M

What is the 1 year trading range for Euda Health Holdings Ltd share price?

Euda Health Holdings Ltd has traded in the range of US$ 0.3269 to US$ 25.70 during the past year

What is the PE ratio of Euda Health Holdings Ltd?

The price to earnings ratio of Euda Health Holdings Ltd is -10.24

What is the cash to sales ratio of Euda Health Holdings Ltd?

The cash to sales ratio of Euda Health Holdings Ltd is 6.67

What is the registered address of Euda Health Holdings Ltd?

The registered address for Euda Health Holdings Ltd is 60 Kaki Bukit Place, Singapore, 415979

What is the Euda Health Holdings Ltd website address?

The website address for Euda Health Holdings Ltd is eudahealth.com

Which industry sector does Euda Health Holdings Ltd operate in?

Euda Health Holdings Ltd operates in the Healthcare Providers & Services sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Euda Health Holdings Ltd (EUDA)

Euda Health Holdings Ltd (EUDA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Euda Health Holdings Ltd について

EUDA 最新ニュース

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

EUDA - Frequently Asked Questions (FAQ)

EUDA 取引

EUDA Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する